{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:35Z","timestamp":1791230735849,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T00:00:00Z","timestamp":1387584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s13277-013-1496-2","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T10:01:31Z","timestamp":1387533691000},"page":"3743-3753","source":"Crossref","is-referenced-by-count":63,"title":["Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Jian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,21]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3322\/CA.2007.0004","volume":"58","author":"N Choong","year":"2008","unstructured":"Choong N, Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin. 2008;58:32\u201353.","journal-title":"CA Cancer J Clin"},{"key":"1496_CR2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212\u201336.","journal-title":"CA Cancer J Clin"},{"key":"1496_CR3","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010;127:2893\u2013917.","journal-title":"Int J Cancer"},{"key":"1496_CR4","unstructured":"Barnes L, Tse LLY, Hunt JL, Brandwein-Gensler M, Urken M, Slootweg P, et al. Chapter 3, Tumors of hypopharynx, larynx and trachea. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 107\u201321."},{"key":"1496_CR5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hed.20811","volume":"30","author":"JP Rodrigo","year":"2008","unstructured":"Rodrigo JP, Suarez C, Silver CE, Rinaldo A, Ambrosch P, Fagan JJ, et al. Transoral laser surgery for supraglottic cancer. Head Neck. 2008;30:658\u201366.","journal-title":"Head Neck"},{"key":"1496_CR6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1496_CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"1496_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/465562a","volume":"465","author":"WG Kaelin Jr","year":"2010","unstructured":"Kaelin Jr WG, Thompson CB. Q&A: cancer: clues from cell metabolism. Nature. 2010;465:562\u20134.","journal-title":"Nature"},{"key":"1496_CR9","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/sj.onc.1209603","volume":"25","author":"SP Mathupala","year":"2006","unstructured":"Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006;25:4777\u201386.","journal-title":"Oncogene"},{"key":"1496_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0005-2728(02)00248-7","volume":"1555","author":"PL Pedersen","year":"2002","unstructured":"Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta. 2002;1555:14\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"1496_CR11","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s11095-011-0584-5","volume":"28","author":"EE Ramsay","year":"2011","unstructured":"Ramsay EE, Hogg PJ, Dilda PJ. Mitochondrial metabolism inhibitors for cancer therapy. Pharm Res. 2011;28:2731\u201344.","journal-title":"Pharm Res"},{"key":"1496_CR12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.18632\/oncotarget.1182","volume":"4","author":"F Sotgia","year":"2013","unstructured":"Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Cancer metabolism: new validated targets for drug discovery. Oncotarget. 2013;4:1309\u201316.","journal-title":"Oncotarget"},{"key":"1496_CR13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00405-007-0394-x","volume":"264","author":"H-U Volker","year":"2007","unstructured":"Volker H-U, Scheich M, Schmausser B, Kammerer U, Eck M. Overexpression of transketolase tktl1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2007;264:1431\u20136.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1496_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","volume":"208","author":"A Wolf","year":"2011","unstructured":"Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208:313\u201326.","journal-title":"J Exp Med"},{"key":"1496_CR15","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2967\/jnumed.108.060780","volume":"50","author":"KJ Ahn","year":"2009","unstructured":"Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, et al. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines. J Nucl Med. 2009;50:1525\u201332.","journal-title":"J Nucl Med"},{"key":"1496_CR16","first-page":"3489","volume":"22","author":"H Mineta","year":"2002","unstructured":"Mineta H, Miura K, Takebayashi S, Misawa K, Araki K, Misawa Y, et al. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Anticancer Res. 2002;22:3489\u201394.","journal-title":"Anticancer Res"},{"key":"1496_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejca.2003.10.024","volume":"40","author":"RJ Oliver","year":"2004","unstructured":"Oliver RJ, Woodwards RTM, Sloan P, Thakker NS, Stratford IJ, Airley RE. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC translational research fund studies. Eur J Cancer. 2004;40:503\u20137.","journal-title":"Eur J Cancer"},{"key":"1496_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1349-7006.2007.00683.x","volume":"99","author":"B Paudyal","year":"2008","unstructured":"Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-d-glucose positron emission tomography. Cancer Sci. 2008;99:260\u20136.","journal-title":"Cancer Sci"},{"key":"1496_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tripleo.2011.04.006","volume":"113","author":"T Yamada","year":"2012","unstructured":"Yamada T, Uchida M, Kwang-Lee K, Kitamura N, Yoshimura T, Sasabe E, et al. Correlation of metabolism\/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:464\u201371.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1496_CR20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/157488607780598269","volume":"2","author":"M Rho","year":"2007","unstructured":"Rho M, Perazella MA. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Curr Drug Saf. 2007;2:147\u201354.","journal-title":"Curr Drug Saf"},{"issue":"10","key":"1496_CR21","doi-asserted-by":"crossref","first-page":"e46591","DOI":"10.1371\/journal.pone.0046591","volume":"7","author":"SA Kwee","year":"2012","unstructured":"Kwee SA, Hernandez B, Chan O, Wong L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival. PLoS One. 2012;7(10):e46591.","journal-title":"PLoS One"},{"key":"1496_CR22","doi-asserted-by":"crossref","unstructured":"Yoshino H, Enokida H, Itesako T, Kojima S, Kinoshita T, Tatarano S, et al. The tumor-suppressive microRNA-143\/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci. 2013;104:1567\u201374.","DOI":"10.1111\/cas.12280"},{"key":"1496_CR23","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/1541-7786.MCR-09-0234","volume":"7","author":"D Palmieri","year":"2009","unstructured":"Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, et al. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res. 2009;7:1438\u201345.","journal-title":"Mol Cancer Res"},{"key":"1496_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2013.09.041","volume":"440","author":"JW Min","year":"2013","unstructured":"Min JW, Kim KI, Kim HA, Kim EK, Noh WC, Jeon HB, et al. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells. Biochem Biophys Res Commun. 2013;440:137\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"1496_CR25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4161\/cbt.7.7.6199","volume":"7","author":"Q Peng","year":"2008","unstructured":"Peng Q, Zhou Q, Zhou J, Zhong D, Pan F, Liang H. Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo. Cancer Biol Ther. 2008;7:1128\u201335.","journal-title":"Cancer Biol Ther"},{"key":"1496_CR26","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2967\/jnumed.111.090266","volume":"52","author":"JE Kim","year":"2011","unstructured":"Kim JE, Ahn B-C, Hwang M-H, Jeon YH, Jeong SY, Lee S-W, et al. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma. J Nucl Med. 2011;52:1756\u201363.","journal-title":"J Nucl Med"},{"key":"1496_CR27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/1535-7163.MCT-07-0115","volume":"6","author":"W Kim","year":"2007","unstructured":"Kim W, Yoon J-H, Jeong J-M, Cheon G-J, Lee T-S, Yang J-I, et al. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma. Mol Cancer Ther. 2007;6:2554\u201362.","journal-title":"Mol Cancer Ther"},{"key":"1496_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85\u201395.","journal-title":"Nat Rev Cancer"},{"key":"1496_CR29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1496_CR30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ceb.2006.10.005","volume":"18","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol. 2006;18:598\u2013608.","journal-title":"Curr Opin Cell Biol"},{"key":"1496_CR31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","volume":"16","author":"N Majewski","year":"2004","unstructured":"Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, et al. Hexokinase\u2013mitochondria interaction mediated by akt is required to inhibit apoptosis in the presence or absence of bax and bak. Mol Cell. 2004;16:819\u201330.","journal-title":"Mol Cell"},{"key":"1496_CR32","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1074\/jbc.M109950200","volume":"277","author":"JG Pastorino","year":"2002","unstructured":"Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002;277:7610\u20138.","journal-title":"J Biol Chem"},{"key":"1496_CR33","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","volume":"65","author":"SJ Yeung","year":"2008","unstructured":"Yeung SJ, Pan J, Lee MH. Roles of p53, myc and hif-1 in regulating glycolysis \u2014 the seventh hallmark of cancer. Cell Mol Life Sci. 2008;65:3981\u201399.","journal-title":"Cell Mol Life Sci"},{"key":"1496_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0194599812464759","volume":"148","author":"DW Li","year":"2013","unstructured":"Li DW, Zhou L, Jin B, Xie J, Dong P. Expression and significance of hypoxia-inducible factor-1alpha and survivin in laryngeal carcinoma tissue and cells. Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg. 2013;148:75\u201381.","journal-title":"Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg"},{"key":"1496_CR35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/00016480310016064","volume":"124","author":"T Krecicki","year":"2004","unstructured":"Krecicki T, Fraczek M, Jelen M, Zatonski T, Szkudlarek T, Dus D. Expression of c-myc oncoprotein in laryngeal squamous cell carcinoma. Acta Otolaryngol. 2004;124:634\u20137.","journal-title":"Acta Otolaryngol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-1496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1496-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:26:48Z","timestamp":1559474808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-1496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,21]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-1496-2","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,21]]}}}